| Dr Gautam Gopalji Jha, MD | |
|
420 Delaware St Se, (dept Of Medicine), Minneapolis, MN 55455-0341 | |
| (612) 624-5373 | |
| Not Available |
| Full Name | Dr Gautam Gopalji Jha |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 26 Years |
| Location | 420 Delaware St Se, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538370622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 50012 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Minnesota Medical Center, Fairview | Minneapolis, MN | Hospital |
| Fairview Ridges Hospital | Burnsville, MN | Hospital |
| Fairview Southdale Hospital | Edina, MN | Hospital |
| Fairview Lakes Health Services | Wyoming, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Express Care | 3375645179 | 1523 |
| Fairview Clinics | 7113830142 | 658 |
News Archive
Every once in a while in the U.S., bacterial meningitis seems to crop up out of nowhere, claiming a young life.
Prothrombin complex concentrates are faster and more effective than fresh frozen plasma at reversing hemorrhage caused by the anti-coagulant warfarin, despite plasma being the most commonly used therapy.
Regen BioPharma, Inc. announced today development of a novel means of delivering its patented (US Patent 8,263,571) gene silencing nucleic acid, RGBP-248, to liver tumors utilizing a clinically approved formulation as delivery system. The product in development overcomes previous hurdles with gene silencing therapeutics in which the gene silencing drug had to be delivered throughout the whole body.
Jintronix, a company radically changing how patients rehabilitate from stroke or other injury, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Jintronix rehabilitation system.
› Verified 7 days ago
| Entity Name | Fairview Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
Every once in a while in the U.S., bacterial meningitis seems to crop up out of nowhere, claiming a young life.
Prothrombin complex concentrates are faster and more effective than fresh frozen plasma at reversing hemorrhage caused by the anti-coagulant warfarin, despite plasma being the most commonly used therapy.
Regen BioPharma, Inc. announced today development of a novel means of delivering its patented (US Patent 8,263,571) gene silencing nucleic acid, RGBP-248, to liver tumors utilizing a clinically approved formulation as delivery system. The product in development overcomes previous hurdles with gene silencing therapeutics in which the gene silencing drug had to be delivered throughout the whole body.
Jintronix, a company radically changing how patients rehabilitate from stroke or other injury, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Jintronix rehabilitation system.
› Verified 7 days ago
| Entity Name | Fairview Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346432218 PECOS PAC ID: 7113830142 Enrollment ID: O20031106000516 |
News Archive
Every once in a while in the U.S., bacterial meningitis seems to crop up out of nowhere, claiming a young life.
Prothrombin complex concentrates are faster and more effective than fresh frozen plasma at reversing hemorrhage caused by the anti-coagulant warfarin, despite plasma being the most commonly used therapy.
Regen BioPharma, Inc. announced today development of a novel means of delivering its patented (US Patent 8,263,571) gene silencing nucleic acid, RGBP-248, to liver tumors utilizing a clinically approved formulation as delivery system. The product in development overcomes previous hurdles with gene silencing therapeutics in which the gene silencing drug had to be delivered throughout the whole body.
Jintronix, a company radically changing how patients rehabilitate from stroke or other injury, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Jintronix rehabilitation system.
› Verified 7 days ago
| Entity Name | Fairview Express Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
Every once in a while in the U.S., bacterial meningitis seems to crop up out of nowhere, claiming a young life.
Prothrombin complex concentrates are faster and more effective than fresh frozen plasma at reversing hemorrhage caused by the anti-coagulant warfarin, despite plasma being the most commonly used therapy.
Regen BioPharma, Inc. announced today development of a novel means of delivering its patented (US Patent 8,263,571) gene silencing nucleic acid, RGBP-248, to liver tumors utilizing a clinically approved formulation as delivery system. The product in development overcomes previous hurdles with gene silencing therapeutics in which the gene silencing drug had to be delivered throughout the whole body.
Jintronix, a company radically changing how patients rehabilitate from stroke or other injury, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Jintronix rehabilitation system.
› Verified 7 days ago
| Entity Name | University Of Minnesota Health Clinics And Surgery Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053795187 PECOS PAC ID: 9133423304 Enrollment ID: O20160209000524 |
News Archive
Every once in a while in the U.S., bacterial meningitis seems to crop up out of nowhere, claiming a young life.
Prothrombin complex concentrates are faster and more effective than fresh frozen plasma at reversing hemorrhage caused by the anti-coagulant warfarin, despite plasma being the most commonly used therapy.
Regen BioPharma, Inc. announced today development of a novel means of delivering its patented (US Patent 8,263,571) gene silencing nucleic acid, RGBP-248, to liver tumors utilizing a clinically approved formulation as delivery system. The product in development overcomes previous hurdles with gene silencing therapeutics in which the gene silencing drug had to be delivered throughout the whole body.
Jintronix, a company radically changing how patients rehabilitate from stroke or other injury, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Jintronix rehabilitation system.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gautam Gopalji Jha, MD 420 Delaware St Se, (dept Of Medicine), Minneapolis, MN 55455-0341 Ph: (612) 624-5373 | Dr Gautam Gopalji Jha, MD 420 Delaware St Se, (dept Of Medicine), Minneapolis, MN 55455-0341 Ph: (612) 624-5373 |
News Archive
Every once in a while in the U.S., bacterial meningitis seems to crop up out of nowhere, claiming a young life.
Prothrombin complex concentrates are faster and more effective than fresh frozen plasma at reversing hemorrhage caused by the anti-coagulant warfarin, despite plasma being the most commonly used therapy.
Regen BioPharma, Inc. announced today development of a novel means of delivering its patented (US Patent 8,263,571) gene silencing nucleic acid, RGBP-248, to liver tumors utilizing a clinically approved formulation as delivery system. The product in development overcomes previous hurdles with gene silencing therapeutics in which the gene silencing drug had to be delivered throughout the whole body.
Jintronix, a company radically changing how patients rehabilitate from stroke or other injury, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Jintronix rehabilitation system.
› Verified 7 days ago
Pascal Frino, M.D Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1 Veterans Dr, Minneapolis, MN 55417 Phone: 612-467-3183 | |
Dr. Ronald Alexander Reilkoff, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 612-672-7422 | |
Eugenia Shmidt, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 507-284-2511 | |
Daniel Tesfaye Kebed, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2450 Riverside Ave, Minneapolis, MN 55454 Phone: 612-672-6000 Fax: 612-273-4098 | |
Tenzin Yangchen, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2925 Chicago Ave, Minneapolis, MN 55407 Phone: 612-863-4000 Fax: 763-236-3026 | |
Shelley M Lennox, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 920 E 28th St, Suite 700, Minneapolis, MN 55407 Phone: 612-863-9062 Fax: 612-863-9252 | |
Dr. Markus Meyer, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2450 Riverside Ave, Minneapolis, MN 55454 Phone: 612-672-6000 |